Cerebrovascular pathology in Down syndrome and Alzheimer disease.

about

Metabolic and Vascular Imaging Biomarkers in Down Syndrome Provide Unique Insights Into Brain Aging and Alzheimer Disease Pathogenesis.The age of onset and evolution of Braak tangle stage and Thal amyloid pathology of Alzheimer's disease in individuals with Down syndrome.

P2860

Q55443889-329355B3-EEF7-422C-ABA0-7B13162DE59F Q55455361-4E07444D-107D-4E8E-A1D5-408900CEB593

P2860

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

Item

http://www.wikidata.org/entity/Q46317444

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@en

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@nl

type

Item

label

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@en

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@nl

prefLabel

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@en

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

@nl

P1476

Cerebrovascular pathology in Down syndrome and Alzheimer disease

@en

P2093

Elizabeth Head

http://www.w3.org/2001/XMLSchema#string

Eric Doran

http://www.w3.org/2001/XMLSchema#string

Frederick A Schmitt

http://www.w3.org/2001/XMLSchema#string

Ira T Lott

http://www.w3.org/2001/XMLSchema#string

Michael J Phelan

http://www.w3.org/2001/XMLSchema#string

Ronald C Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Intracerebral haemorrhage in Down syndrome: protected or predisposed?

Neuropathological diagnosis of vascular cognitive impairment and vascular dementia with implications for Alzheimer's disease

Lymphatic Clearance of the Brain: Perivascular, Paravascular and Significance for Neurodegenerative Diseases

Structural basis of C-terminal β-amyloid peptide binding by the antibody ponezumab for the treatment of Alzheimer's disease

Neuropathological stageing of Alzheimer-related changes

Warfarin-associated hemorrhage and cerebral amyloid angiopathy: a genetic and pathologic study.

Vascular pathology in the aged human brain

Cerebral amyloid angiopathy as a cause of an extensive brain hemorrhage in adult patient with Down's syndrome - a case report.

Contribution of vascular pathology to the clinical expression of dementia.

Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Neuropathology Group of the Medical Research Council Cognitive Function and Ageing Study (MRC CFAS).

P2888

s40478-017-0499-4

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S40478-017-0499-4

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Wayne W Poon

P577

2017-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1093095312

http://www.w3.org/2001/XMLSchema#string

P698

29195510

http://www.w3.org/2001/XMLSchema#string

P921

Alzheimer's disease

P932

5709935

http://www.w3.org/2001/XMLSchema#string

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

about

P2860

P2860

Cerebrovascular pathology in Down syndrome and Alzheimer disease.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P932